Loading
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 05 Jun 2026 for Myriad Genetics INC.
Insider track record
Disclosed buys
0
Disclosed sells
0
T+90 hit rate
0%
T+90 mean return
-35.3%
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Mark Steven Davis: trading record in brief
Mark Steven Davis discloses dealings in 2 companies, chiefly Myriad Genetics Inc and Yext, Inc. We count 4 filings; the first trade dates from 12 June 2024 and the latest from 4 June 2026.
The filings describe grants, exercises and other transfers rather than trades on the open market. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
The latest filing, published on 5 June 2026, reports a share grant in Myriad Genetics Inc. Typically, a trade is published a median of 1 day after it takes place. The legal deadline for a Form 4 is two business days after the transaction. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Mark Steven Davis
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations4 total
59,701 shares0Common StockSEC:0002024613-26-000002:0
24,148 shares0Common StockSEC:0001628280-25-029977:0
22,816 shares0Common StockSEC:0001628280-24-050787:0
62,500 shares0Common StockSEC:0001614178-24-000077:0
4 of 4 declarations
